Literature DB >> 12590608

Catalytic and regulatory domains of doublecortin kinase-1.

Limin Shang1, Young-Guen Kwon, Sandip Nandy, David S Lawrence, Arthur M Edelman.   

Abstract

Doublecortin kinase-1 (DCK1) is a newly described multidomain protein kinase with a sequence significantly similar to those of both CaM kinases (CaMKs) and doublecortin, the product of the gene mutated in X-linked lissencephaly/double cortex syndrome, a severe developmental disorder of the nervous system. Functional studies have revealed microtubule binding and polymerization activities of the doublecortin domain, yet little is known regarding the enzymatic properties and regulation of the kinase catalytic domain. We have identified and report here notable similarities as well as differences between the catalytic and regulatory properties of DCK1 and those of the CaMKs. Using synthetic peptide substrates modeled on synapsin I, a substrate recognition motif for DCK1 of Hyd-Arg-Arg-X-X-Ser/Thr-Hyd was derived. The similarity of this motif to that of CaMKI [Lee, J. C., Kwon, Y.-G., Lawrence, D. S., and Edelman, A. M. (1994) Proc. Natl. Acad. Sci. U.S.A. 91, 6413-6417] is consistent with the 59% level of amino acid sequence similarity between their catalytic domains. DCK1 catalytic activity is enhanced by mutagenic introduction of negative charge at Thr-239, a residue in a position equivalent to that of Thr-177 of CaMKI, the activation loop site for regulation by CaM kinase kinase. Unlike CaMKs, DCK1 is not directly activated by Ca(2+)-bound CaM. However, truncation of a pseudosubstrate-like sequence in the C-terminus of DCK1 results in an approximately 6-fold enhancement of activity. Thus, DCK1 demonstrates the potential to be regulated by relief of autoinhibition in response to signal(s) distinct from Ca(2+)-bound CaM and potentially by activation loop phosphorylation and to phosphorylate intracellular targets at sites similar to those recognized by CaMK pathways.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12590608     DOI: 10.1021/bi026913i

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  11 in total

1.  Doublecortin-like Kinase 1 Regulates α-Synuclein Levels and Toxicity.

Authors:  Gabriel E Vázquez-Vélez; Kristyn A Gonzales; Jean-Pierre Revelli; Carolyn J Adamski; Fatemeh Alavi Naini; Aleksandar Bajić; Evelyn Craigen; Ronald Richman; Sabrina M Heman-Ackah; Matthew J A Wood; Maxime W C Rousseaux; Huda Y Zoghbi
Journal:  J Neurosci       Date:  2019-11-20       Impact factor: 6.167

2.  Epigenetic regulation of human DCLK-1 gene during colon-carcinogenesis: clinical and mechanistic implications.

Authors:  Pomila Singh; Malaney O'Connell; Sarkar Shubhashish
Journal:  Stem Cell Investig       Date:  2016-09-28

3.  Doublecortin-like kinase 1 exhibits cancer stem cell-like characteristics in a human colon cancer cell line.

Authors:  Lianna Li; Charles F Bellows
Journal:  Chin J Cancer Res       Date:  2013-04       Impact factor: 5.087

4.  Can subtle changes in gene expression be consistently detected with different microarray platforms?

Authors:  Paola Pedotti; Peter A C 't Hoen; Erno Vreugdenhil; Geert J Schenk; Rolf Ham Vossen; Yavuz Ariyurek; Mattias de Hollander; Rowan Kuiper; Gertjan J B van Ommen; Johan T den Dunnen; Judith M Boer; Renée X de Menezes
Journal:  BMC Genomics       Date:  2008-03-10       Impact factor: 3.969

5.  Doublecortin-like kinase 1 compromises DNA repair and induces chromosomal instability.

Authors:  Yuxiong Lu; Junichi Maruyama; Keiko Kuwata; Hiroyuki Fukuda; Hiroaki Iwasa; Kyoko Arimoto-Matsuzaki; Haruhiko Sugimura; Yutaka Hata
Journal:  Biochem Biophys Rep       Date:  2018-10-30

6.  LncRNA SNHG1 promotes EMT process in gastric cancer cells through regulation of the miR-15b/DCLK1/Notch1 axis.

Authors:  Zhi-Qi Liu; Wei-Feng He; Yang-Jie Wu; Shun-Li Zhao; Ling Wang; Yan-Yi Ouyang; San-Yuan Tang
Journal:  BMC Gastroenterol       Date:  2020-05-18       Impact factor: 3.067

7.  Deep sequencing-based expression analysis shows major advances in robustness, resolution and inter-lab portability over five microarray platforms.

Authors:  Peter A C 't Hoen; Yavuz Ariyurek; Helene H Thygesen; Erno Vreugdenhil; Rolf H A M Vossen; Renée X de Menezes; Judith M Boer; Gert-Jan B van Ommen; Johan T den Dunnen
Journal:  Nucleic Acids Res       Date:  2008-10-15       Impact factor: 16.971

8.  Epigenetic changes and alternate promoter usage by human colon cancers for expressing DCLK1-isoforms: Clinical Implications.

Authors:  Malaney R O'Connell; Shubhashish Sarkar; Gurinder K Luthra; Yoshinaga Okugawa; Yuji Toiyama; Aakash H Gajjar; Suimin Qiu; Ajay Goel; Pomila Singh
Journal:  Sci Rep       Date:  2015-10-08       Impact factor: 4.379

9.  The microtubule-associated protein DCAMKL1 regulates osteoblast function via repression of Runx2.

Authors:  Weiguo Zou; Matthew B Greenblatt; Nicholas Brady; Sutada Lotinun; Bo Zhai; Heather de Rivera; Anju Singh; Jun Sun; Steven P Gygi; Roland Baron; Laurie H Glimcher; Dallas C Jones
Journal:  J Exp Med       Date:  2013-08-05       Impact factor: 14.307

10.  Doublecortin-like kinase enhances dendritic remodelling and negatively regulates synapse maturation.

Authors:  Euikyung Shin; Yutaro Kashiwagi; Toshihiko Kuriu; Hirohide Iwasaki; Teruyuki Tanaka; Hiroyuki Koizumi; Joseph G Gleeson; Shigeo Okabe
Journal:  Nat Commun       Date:  2013       Impact factor: 14.919

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.